135 related articles for article (PubMed ID: 15188848)
1. Failure to develop vancomycin-resistant Enterococcus with oral vancomycin treatment of Clostridium difficile.
Salgado CD; Giannetta ET; Farr BM
Infect Control Hosp Epidemiol; 2004 May; 25(5):413-7. PubMed ID: 15188848
[TBL] [Abstract][Full Text] [Related]
2. Skin and environmental contamination with vancomycin-resistant Enterococci in patients receiving oral metronidazole or oral vancomycin treatment for Clostridium difficile-associated disease.
Sethi AK; Al-Nassir WN; Nerandzic MM; Donskey CJ
Infect Control Hosp Epidemiol; 2009 Jan; 30(1):13-7. PubMed ID: 19046063
[TBL] [Abstract][Full Text] [Related]
3. Duration of colonization with vancomycin-resistant Enterococcus.
Byers KE; Anglim AM; Anneski CJ; Farr BM
Infect Control Hosp Epidemiol; 2002 Apr; 23(4):207-11. PubMed ID: 12002235
[TBL] [Abstract][Full Text] [Related]
4. Lack of increased colonization with vancomycin-resistant enterococci during preferential use of vancomycin for treatment during an outbreak of healthcare-associated Clostridium difficile infection.
Miller M; Bernard L; Thompson M; Grima D; Pepin J
Infect Control Hosp Epidemiol; 2010 Jul; 31(7):710-5. PubMed ID: 20518636
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for systemic vancomycin exposure following administration of oral vancomycin for the treatment of Clostridium difficile infection.
Pettit NN; DePestel DD; Fohl AL; Eyler R; Carver PL
Pharmacotherapy; 2015 Feb; 35(2):119-26. PubMed ID: 25689243
[TBL] [Abstract][Full Text] [Related]
6. Molecular epidemiology and risk factors for colonization by vancomycin-resistant Enterococcus in patients with hematologic malignancies.
Almyroudis NG; Lesse AJ; Hahn T; Samonis G; Hazamy PA; Wongkittiroch K; Wang ES; McCarthy PL; Wetzler M; Segal BH
Infect Control Hosp Epidemiol; 2011 May; 32(5):490-6. PubMed ID: 21515980
[TBL] [Abstract][Full Text] [Related]
7. Characterization of continued antibacterial therapy after diagnosis of hospital-onset Clostridium difficile infection: implications for antimicrobial stewardship.
Harpe SE; Inocencio TJ; Pakyz AL; Oinonen MJ; Polk RE
Pharmacotherapy; 2012 Aug; 32(8):744-54. PubMed ID: 23307522
[TBL] [Abstract][Full Text] [Related]
8. Duration of colonization and risk factors for prolonged carriage of vancomycin-resistant enterococci after discharge from the hospital.
Sohn KM; Peck KR; Joo EJ; Ha YE; Kang CI; Chung DR; Lee NY; Song JH
Int J Infect Dis; 2013 Apr; 17(4):e240-6. PubMed ID: 23195640
[TBL] [Abstract][Full Text] [Related]
9. Tapering Courses of Oral Vancomycin Induce Persistent Disruption of the Microbiota That Provide Colonization Resistance to Clostridium difficile and Vancomycin-Resistant Enterococci in Mice.
Tomas ME; Mana TSC; Wilson BM; Nerandzic MM; Joussef-Piña S; Quiñones-Mateu ME; Donskey CJ
Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29530853
[TBL] [Abstract][Full Text] [Related]
10. Comparison of treatment outcomes with vancomycin alone versus combination therapy in severe Clostridium difficile infection.
Bass SN; Bauer SR; Neuner EA; Lam SW
J Hosp Infect; 2013 Sep; 85(1):22-7. PubMed ID: 23876778
[TBL] [Abstract][Full Text] [Related]
11. [Vancomycin-resistant enterococcus colonization in neonatal intensive care unit: prevention and eradication experience].
Benzer D; Yavuzcan Öztürk D; Gürsoy T; Ocalmaz MS; Karatekin G; Ovalı HF
Mikrobiyol Bul; 2012 Oct; 46(4):682-8. PubMed ID: 23188582
[TBL] [Abstract][Full Text] [Related]
12. Vancomycin-resistant Clostridium innocuum bacteremia following oral vancomycin for Clostridium difficile infection.
Hung YP; Lin HJ; Wu CJ; Chen PL; Lee JC; Liu HC; Wu YH; Yeh FH; Tsai PJ; Ko WC
Anaerobe; 2014 Dec; 30():24-6. PubMed ID: 25102472
[TBL] [Abstract][Full Text] [Related]
13. Incidence and risk factors of vancomycin-resistant enterococcus colonization in burn unit patients.
Altoparlak U; Koca O; Ozkurt Z; Akcay MN
Burns; 2011 Feb; 37(1):49-53. PubMed ID: 20926196
[TBL] [Abstract][Full Text] [Related]
14. Recurrence of vancomycin-resistant Enterococcus stool colonization during antibiotic therapy.
Donskey CJ; Hoyen CK; Das SM; Helfand MS; Hecker MT
Infect Control Hosp Epidemiol; 2002 Aug; 23(8):436-40. PubMed ID: 12186208
[TBL] [Abstract][Full Text] [Related]
15. A hospital epidemic of vancomycin-resistant Enterococcus: risk factors and control.
Byers KE; Anglim AM; Anneski CJ; Germanson TP; Gold HS; Durbin LJ; Simonton BM; Farr BM
Infect Control Hosp Epidemiol; 2001 Mar; 22(3):140-7. PubMed ID: 11310691
[TBL] [Abstract][Full Text] [Related]
16. Tolerance of vancomycin for surgical prophylaxis in patients undergoing cardiac surgery and incidence of vancomycin-resistant enterococcus colonization.
Kachroo S; Dao T; Zabaneh F; Reiter M; Larocco MT; Gentry LO; Garey KW
Ann Pharmacother; 2006 Mar; 40(3):381-5. PubMed ID: 16478809
[TBL] [Abstract][Full Text] [Related]
17. The epidemiology of vancomycin-resistant Enterococcus colonization in a medical intensive care unit.
Warren DK; Kollef MH; Seiler SM; Fridkin SK; Fraser VJ
Infect Control Hosp Epidemiol; 2003 Apr; 24(4):257-63. PubMed ID: 12725354
[TBL] [Abstract][Full Text] [Related]
18. Outpatient vancomycin use and vancomycin-resistant enterococcal colonization in maintenance dialysis patients.
Atta MG; Eustace JA; Song X; Perl TM; Scheel PJ
Kidney Int; 2001 Feb; 59(2):718-24. PubMed ID: 11168954
[TBL] [Abstract][Full Text] [Related]
19. Laboratory-based surveillance for vancomycin-resistant enterococci: utility of screening stool specimens submitted for Clostridium difficile toxin assay.
Leber AL; Hindler JF; Kato EO; Bruckner DA; Pegues DA
Infect Control Hosp Epidemiol; 2001 Mar; 22(3):160-4. PubMed ID: 11310695
[TBL] [Abstract][Full Text] [Related]
20. Incidence and clinical complications of vancomycin-resistant enterococcus in pediatric stem cell transplant patients.
Tsiatis AC; Manes B; Calder C; Billheimer D; Wilkerson KS; Frangoul H
Bone Marrow Transplant; 2004 May; 33(9):937-41. PubMed ID: 15034540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
